Approx 2 hours long.... but highlights the new-found focus/push on alzheiners in USA.... and some of the issues with funding / progress / care-giving / minorities / Medicade etc.
Shows why Pharma... if funding their own trials... want testing / recruiting streamlined (with help from the likes of Cogstate) as much as possible.... given somewhat sluggish help from government at this stage.
This is the full US Senate sitting... where B Smith and her husband appear.... and make those at the Senate meeting more aware of the "Brain Health Registry".... and the reason why the registry is being build up.
Fundamentals don't matter squat as regards the CGS share price.... but the video at least fills in some of the gaps as to what is happening over in USA.
Note: Cogstate tests are relevant to cognition testing not just in Alzheimers trials.... but in many other trials as listed in latest presso.
bsh
CGS Price at posting:
23.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)